Today
@today·5M subscribers·54.4K videos
Novo Nordisk sues companies for ‘misbranding’ copycat Ozempic
Posted
December 1, 2023
Views
1,134
Likes
13
Comments
1
Engagement
1.23%
December 1, 2023
1,134
13
1
1.23%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:58Now PlayingDrugs like Ozempic and Wegovy are helping people slim down with the help of injectable medicine, but now Novo Nordisk is filing a lawsuit against two companies, alleging they have misbranded compounded drugs claiming to contain semaglutide, the key patented ingredient that blunts hunger. NBC’s Christine Romans reports for TODAY.
» Subscribe to TODAY
» Watch the latest from TODAY
About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website
Find TODAY on Facebook
Follow TODAY on Twitter
Follow TODAY on Instagram
» Stream TODAY All Day
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#ozempic #weightloss #health
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
